A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 157,000 shares of RXST stock, worth $8.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
157,000
Holding current value
$8.82 Million
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$35.51 - $57.92 $5.58 Million - $9.09 Million
157,000 New
157,000 $8.1 Million
Q2 2023

Aug 11, 2023

BUY
$16.37 - $28.9 $402,702 - $710,940
24,600 Added 172.03%
38,900 $1.12 Million
Q1 2023

May 12, 2023

BUY
$12.58 - $16.68 $179,894 - $238,524
14,300 New
14,300 $239,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.55B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.